MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
about
Magnetic resonance frequency shifts during acute MS lesion formationRevised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisCurrent and new directions in MRI in multiple sclerosisMeasuring longitudinal myelin water fraction in new multiple sclerosis lesions.Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.MRI in multiple sclerosis: what's inside the toolbox?Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential?Clinically presenting acute/subacute ischemic stroke: differential diagnosis of the non-enhanced CT hypodensity by advanced neuroimaging.Multiple sclerosis lesions: insights from imaging techniques.Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?Seasonal prevalence of MS disease activityClinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques.Acute demyelinating lesions with restricted diffusion in multiple sclerosis.The blood-brain barrier in health and disease.Spinal cord ring enhancement in multiple sclerosisSera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierCerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy.Comparison of standard 1.5 T vs. 3 T optimized protocols in patients treated with glatiramer acetate. A serial MRI pilot study.Defining Disease Activity and Response to Therapy in MS.Neuroradiological evaluation of demyelinating diseaseMagnetic resonance monitoring of lesion evolution in multiple sclerosisQuantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS.Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis.Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.Imaging in multiple sclerosis: A new spin on lesions.Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.Automated identification of brain new lesions in multiple sclerosis using subtraction images.MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
P2860
Q22065276-19D9E939-8457-4EF4-9EAA-AF0A68CE971EQ30278095-E79D728B-0ABF-4CD4-9168-81284D801A2EQ30659431-21CE7677-AC69-4A23-BD85-2C342F17A684Q31027246-E83816B2-4749-44B7-AA43-F26084DD09F7Q31037055-F8743167-1B66-49F0-A1B6-95298703DDC7Q31132442-EFA6E60D-87B0-4473-B960-63B93B342448Q33289264-F5C9A841-9DEA-47C6-A2BD-614A8667D7ECQ33499133-5FE50B84-7C88-413B-9E31-807635A5B3CFQ33505423-F3C2FDE0-3E8B-4A8D-AE34-6D60B46504E1Q33708751-BBAC0E00-3CE5-497C-8D99-F14C468FE47DQ34010780-FD7DEA8A-30A0-4F36-9C7A-2F7658156DCCQ34125522-DE5ED7E2-4A0E-4FC4-9A2D-C57E3A3712E8Q34171891-B61802D7-0F54-4887-ACE5-3562E04B0832Q34241405-17D7A188-6AAE-44E7-85EF-65009B72822FQ34320420-A8A818A8-0958-45C1-ACA0-07BA15BDE428Q34675159-4BEAFA33-1141-4E8A-AB17-60C4D80C18B4Q35136280-5EC29BBD-A70B-4349-BD4A-781034D4ECC3Q35720710-80A984C6-402D-48AB-8F29-75D67A668D44Q35823723-CB6C0510-7D6D-4830-B4F7-9B24A668BBCBQ36057186-A03D9937-2326-4E49-A322-A7B2E1B81144Q36357501-E01029F1-3F4C-43A6-B671-09FDE820FF44Q36999734-8F32066A-8EEA-4B04-8229-D4A40A799B4AQ37127555-0F9AE735-51DE-46D4-848D-320ED9AB8ED6Q37246750-7EE42342-6622-4C55-9A19-84E33BB1799EQ37254889-7754CBFB-EEE8-47C8-B357-A1FC2CE875EFQ37605738-0A37702D-6321-4A78-A7D9-BDCE97C3D7F0Q37893199-5914E636-1AEF-418D-AD9D-6598FADFFDC6Q38658313-E6B15A31-DFA2-419C-8E93-91E2F29379D5Q38837567-24977294-61D3-4379-8BFD-E0AA0CF38F5EQ38844529-CAC69542-9404-48D0-82AA-F96A5E59BDFFQ38910256-3FC1579B-88AD-4220-BAF1-FC534C84FFADQ39247449-2045BF99-7A1E-4B5A-9A2B-79D04D8C36B6Q41687816-AEF80D50-9FDB-4D59-81B4-5E94A6F44C10Q47144073-8DD079B8-F29A-4E57-903F-4CCBCF5D7E73Q48119217-E930EA9B-9836-4909-806C-504B2D805C53Q48179143-2224AD21-3B6D-4F41-887E-0AF4E5561166Q48427400-968AD2A3-7455-434E-BF91-A6AEAB92EA3DQ48682011-4392D3C2-A509-44F7-8A04-514856D558F9Q49606221-92D0EEE5-E10A-4F43-A374-070B9106C0B4Q51108248-1F974120-4ECA-4A20-8270-CCB6C3B5D64A
P2860
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
MRI contrast uptake in new les ...... followed at weekly intervals.
@en
MRI contrast uptake in new les ...... followed at weekly intervals.
@nl
type
label
MRI contrast uptake in new les ...... followed at weekly intervals.
@en
MRI contrast uptake in new les ...... followed at weekly intervals.
@nl
prefLabel
MRI contrast uptake in new les ...... followed at weekly intervals.
@en
MRI contrast uptake in new les ...... followed at weekly intervals.
@nl
P50
P1433
P1476
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
@en
P2093
Ferenc A Jolesz
P304
P356
10.1212/01.WNL.0000046587.83503.1E
P407
P577
2003-02-01T00:00:00Z